Intravenous Infusions (XGHA:IIL) Current Deferred Taxes Liabilities: GHS0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XGHA:IIL Intravenous Infusions Ltd XGHA:IIL
3 GF Score
Price GHS0.46
View Full Analysis

What is Intravenous Infusions Current Deferred Taxes Liabilities?

Intravenous Infusions XGHA:IIL +6.98% 3 Current Deferred Taxes Liabilities is GHS0.00 Mil as of . 20. GuruFocus rates XGHA:IIL with a GF Score™ of 3/100.

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Intravenous Infusions's current deferred tax liabilities for the quarter that ended in . 20 was GHS0.00 Mil.

Intravenous Infusions Current Deferred Taxes Liabilities Related Terms

Intravenous Infusions Current Deferred Taxes Liabilities Historical Data

* Premium members only.

The historical data trend for Intravenous Infusions's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intravenous Infusions Current Deferred Taxes Liabilities Chart

Intravenous Infusions Annual Data
Trend
Current Deferred Taxes Liabilities

Intravenous Infusions Semi-Annual Data
Current Deferred Taxes Liabilities
XGHA:IIL
3GF Score
Intravenous Infusions Ltd XGHA:IIL
Current Deferred Taxes Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Taxes Liabilities of GHS0.00 Mil mean?
Intravenous Infusions (XGHA:IIL) has a Current Deferred Taxes Liabilities of GHS0.00 Mil as of . 20. Current Deferred Tax Liabilities records the total amount of taxes due for the period but not yet paid. View historical data on Intravenous Infusions and its competitors.
Is Intravenous Infusions' Current Deferred Taxes Liabilities too high?
Intravenous Infusions' current Current Deferred Taxes Liabilities is GHS0.00 Mil. Overall, Intravenous Infusions has a GF Score™ of 3/100, reflecting its overall financial health beyond just this single metric.
How does Intravenous Infusions' Current Deferred Taxes Liabilities compare to PTLF and PCYN?
Intravenous Infusions' Current Deferred Taxes Liabilities of GHS0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Taxes Liabilities for a Drug Manufacturers company?
A good Current Deferred Taxes Liabilities depends on the Drug Manufacturers industry context. However, Current Deferred Taxes Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Taxes Liabilities mean?
A high Current Deferred Taxes Liabilities can signal that a stock is expensive relative to its fundamentals. Current Deferred Tax Liabilities records the total amount of taxes due for the period but not yet paid. View historical data on Intravenous Infusions and its competitors. Intravenous Infusions's current Current Deferred Taxes Liabilities is GHS0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intravenous Infusions stock overvalued right now?
Intravenous Infusions (XGHA:IIL) has a current Current Deferred Taxes Liabilities of GHS0.00 Mil. The current Current Deferred Taxes Liabilities is GHS0.00 Mil. Intravenous Infusions' overall GF Score™ is 3/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Taxes Liabilities calculated?
Current Deferred Taxes Liabilities is calculated from a company's financial statements. For Intravenous Infusions (XGHA:IIL), the current Current Deferred Taxes Liabilities is GHS0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Intravenous Infusions Business Description

Address Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.
3GF Score

Get the complete analysis for XGHA:IIL

Current Deferred Taxes Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

GHS0.46
Price